Literature DB >> 31738640

Association of Neuregulin 1 rs7835688 G > C, rs16879552 T > C and rs2439302 G > C Polymorphisms with Susceptibility to Non-Syndromic Hirschsprung's Disease.

Seyed Hamed Hosseini-Jangjou1, Seyed Alireza Dastgheib2, Majid Aflatoonian3, Abdolhamid Amooee4, Reza Bahrami5, Elham Salehi6, Jalal Sadeghizadeh-Yazdi7, Hossein Neamatzadeh8,9.   

Abstract

BACKGROUND: Hirschsprung's disease (HSCR) is a heterogeneous congenital malformation of the enteric nervous system with a complex genetic etiology. We investigated if there was an association between Neuregulin-1 (NRG1) rs7835688 G > C, rs16879552 T > C and rs2439302 G > C polymorphisms and the risk of HSCR.
Methods: We determined and compared the frequency of NRG1 polymorphisms rs7835688 G > C, rs16879552 T > C and rs2439302 G > C in 70 children with HSCR and 90 controls by TaqMan SNPs genotyping assays.
Results: No significant differences in allele or genotype frequencies of NRG1 rs7835688 G > C, rs16879552 T > C and rs2439302 G > C polymorphisms were observed between HSCR cases and controls. Analyses showed that the NRG1 rs7835688 G > C, rs16879552 T > C and rs2439302 G > C polymorphisms were not significantly associated with an increased risk of non-syndromic HSCR. Conclusions: Our findings suggested that NRG1 rs7835688 G > C, rs16879552 T > C and rs2439302 G > C polymorphisms are not a risk factor in development of HSCR.

Entities:  

Keywords:  Hirschsprung’s disease; Neuregulin 1; association; non-syndromic; polymorphism

Mesh:

Substances:

Year:  2019        PMID: 31738640     DOI: 10.1080/15513815.2019.1692113

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  1 in total

1.  Investigating the Association Between rs2439302 Polymorphism and Thyroid Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yawen Guo; Wanchen Zhang; Ru He; Chuanming Zheng; Xuefeng Liu; Minghua Ge; Jiajie Xu
Journal:  Front Surg       Date:  2022-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.